Comparing the Add on Effectiveness of Intra-Articular Injections of High Molecular Weight Hyaluronic Acid (Viscor®>2000 KD) with Low Molecular Weight Hyaluronic Acid (Hyalgan® MW= 500-800 KD) and Lidocaine In Frozen Shoulder Conventional Physical Therapy.
Phase 3
- Conditions
- Idiopathic Adhesive Capsulitis (Frozen Shoulder).Adhesive capsulitis of unspecified shoulderM75.00
- Registration Number
- IRCT20170608034390N4
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Adults (>18 years)
Less than 65 years old
It takes less than three month from the onset of the disorder
Exclusion Criteria
History of Traumatic Injury to the shoulder
Active Tendonitis
History of rotator cuff tear
History of NSAIDs use during the last week
History of systemic corticosteroid use during the last 1 month
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: At baseline, 4, 12 and 24 weeks after injection. Method of measurement: Visual Analog Scale.
- Secondary Outcome Measures
Name Time Method Range of Motion. Timepoint: At baseline, 4 and 12 weeks after injection. Method of measurement: Goniometry.;Inflammation Signs and Symptoms. Timepoint: at baseline of injection. Method of measurement: Hyperemia, Warmly, Pain, Tendonitis, Tenderness.;Oxford Shoulder Score. Timepoint: At baseline, 4 and 12 weeks after injection. Method of measurement: Oxford Questionnaire.